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Abstract
The aim of this study was to compare the performances of two strategies for predicting intra-
partum vaginal carriage of group B streptococci (GBS). One strategy was based on an ante-
partum culture and the other on an intrapartum polymerase chain reaction (PCR). We
conducted a prospective observational study enrolling 902 pregnant women offered GBS
screening before delivery by two strategies. The Culture-strategy was based on vaginal and
rectal cultures at 35–37 weeks’ gestation, whereas the PCR-strategy was based on PCR
assay on intrapartum vaginal swab samples. An intrapartum vaginal culture for GBS was
used as the reference standard from which the performances of the 2 strategies were evalu-
ated. The reference standard showed a GBS-prevalence of 12%. The culture-strategy per-
formed with a sensitivity of 82%, specificity of 91%, positive predictive value (PPV) of 55%,
negative predictive value (NPV) of 98%, and Likelihood ratio (LH+) of 9.2. The PCR-strategy
showed corresponding values as sensitivity of 83%, specificity of 97%, PPV of 78%, NPV of
98%, and LH+ of 27.5. We conclude that in a Danish population with a low rate of early-
onset neonatal infection with GBS, the intrapartum PCR assay performs better than the
antepartum culture for identification of GBS vaginal carriers during labor.
Introduction
Even though early-onset neonatal infection with Group B streptococci (EOGBS) is rare, it still
constitutes a health problem in countries where the prevalence of EOGBS disease is 2 in 1,000
live births, and the mortality rate is 50% [1]. As EOGBS [2] occurs only among the group of
neonates who are born by the 10–35% of women colonized vaginally with GBS [3–8], the Cen-
ters for Disease Control and Prevention (CDC), USA, in 2002 recommended universal culture
screening of all pregnant women between 35 and 37 weeks’ gestation in order to give intrapar-
tum antibiotics to the screen positives [9, 10]. The implementation of this strategy was
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followed by a decrease in the EOGBS rate from 1.5 to 0.4/1,000 live births [9]. This decrease
must be categorized as a success, however, one might wonder why the EOGBS rate in some
other countries including Denmark is only 0.1–0.4/1,000 live births [11] even though they
have not implemented this antepartum culture-based screening program.
A weakness of the CDC strategy based on a rectovaginal culture obtained often weeks
before labor is that shifts in the GBS status [2] reduces the sensitivity to about 50% [12] and
positive predictive value to about 60% [13, 14]. This explains why the majority of neonates
with EOGBS in the USA are born by women with a negative test for GBS [15–17]. Further-
more, it may cause an overuse of antibiotics if a test for GBS has been positive at a preterm
screening but GBS is no longer present at delivery [18, 19]. However, changes in the GBS colo-
nization status of the mother during the period between antepartum screening and delivery
may be influenced by several factors including a low colonization status of the woman, subop-
timal timing of specimen collection, and inappropriate transport media for specimens, such as
lack of storage at 5˚C if transportation of specimens for culture is delayed or there is inade-
quate laboratory processing [20].
These data call for a rapid GBS test that can be used intrapartum for better identification of
women carrying GBS in the vagina at the time of delivery. Previous studies have shown that
the sensitivity of the intrapartum polymerase chain reaction test (PCR) to detect GBS coloniza-
tion during labor may be superior to antenatal cultures; however, these differences have not
always been statistically significant [14, 21–23].
The BD Max GBS assay (BD Diagnostic Systems, Que´bec, Canada) performed on the
BDMax™ system (BD Diagnostic Systems, Sparks, MD) is a PCR test intended for use with
enriched Lim broth culture after 18 h of incubation of vaginal/rectal swab samples and can
provide results for up to 24 concurrent specimens in approximately 2.5 h. The use of E-Swab
samples with the BDMax™ GBS assay, eliminating the Lim broth inoculation and incubation
steps, may enable a rapid detection of GBS in pregnant women at birth with a sensitivity of
93% [24]. The performance of such an intrapartum PCR-test without a prior enriched Lim
broth culture, however, has never been evaluated in a Danish population of pregnant women
with a low risk of their babies acquiring early-onset neonatal group B streptococcal disease.
Therefore, the aim of this study was to compare the performance of an antepartum culture
based screening strategy and an intrapartum PCR assay for the prediction of intrapartum vagi-
nal carriage of group B streptococci (GBS) in a Danish cohort, using intrapartum vaginal cul-
ture as the reference standard.
Material and methods
A total of 2,343 pregnant women attending the prenatal clinic at Lillebaelt Hospital, Kolding,
Denmark (with an average of 3,200 deliveries per year) over a 15 months’ period between
April 2013 and June 2014 were invited to participate in this prospective observational study.
One thousand three hundred sixty-four (n = 1,364) declined to participate, leaving 979 partici-
pants in the final cohort (Fig 1). Detailed information on oral antibiotic use during pregnancy
was obtained from registered data in both patient hospital records and the Danish Medical
Agency’s Register of non-hospitalized patient use, which included records on all drug prescrip-
tions filed at any Danish pharmacy. Five patients received antibiotics after week 35 of gestation
and were therefore excluded (Fig 1). Further, sixty women withdrew from the study at the
time of birth for various reasons. Twelve were lost for follow-up. Thus, 902 sets of patient sam-
ples were available for comparisons between antepartum culture (culture-based screening)
and PCR analysis (PCR-based screening) with intrapartum culture.
Intrapartum PCR assay versus antepartum culture
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Inclusions criteria
All pregnant women attending the prenatal Clinic at Lillebaelt Hospital, Kolding were invited
to participate.
Exclusions criteria
Women who delivered preterm (< 37 weeks´ gestation)
Women who received antibiotics after 35 weeks´ gestation
Women with communication restrictions
Women under 18 years old were excluded.
Collection of specimens
All samples were collected using nylon flocked swabs submerged separately into 1 ml of
E-Swab transport medium (E-Swab, Copan Diagnostics, Brescia, Italy).
• The Culture-strategy: At 35–37 weeks’ gestation, each participant obtained a self-adminis-
tered and time-saving vaginal and rectal swab sample for culture during a planned visit to
the outpatient clinic [25, 26].
• The reference standard: During labor, the midwife collected a vaginal swab sample which
was used for immediately culture of GBS.
• The PCR-strategy: The vaginal swab obtained during labor as intrapartum culture sample
(reference standard), submerged into the transport medium, was frozen at minus 80˚C for
later GBS PCR analysis as a batch processing.
Fig 1. Flowchart of the population.
https://doi.org/10.1371/journal.pone.0180262.g001
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In addition to the written information with text and drawings on how women should
obtain a self-administered vaginal and rectal swab sample for the culture, two instructional
videos were available to all participants on the project website. The sampling was carried out
by inserting and rotating one E-Swab 1.5–2 cm inside the vagina and another one in the rec-
tum by inserting the swab 1.5–2 cm beyond the anal sphincter. All samples were analyzed at
the Department of Clinical Microbiology, Lillebaelt Hospital, Vejle, Denmark.
Culture of specimens
Samples were cultured at the time of arrival to the laboratory; if received after 8 PM, they were
kept at 4˚C until the next morning. Broth enrichment was not employed as part of a strategy
to simulate and evaluate a rapid testing of the presence of GBS in the vaginal samples by both
culture and PCR. Therefore, direct plating without prior enrichment of the specimen in a cul-
ture broth was carried out by streaking the E-Swab specimen on a selective Granada agar plate.
The vaginal and rectal swabs from the same patient were seeded on different sides of the same
Granada agar plate (BioMe´rieux1, Spain). The Granada agar plates were incubated immedi-
ately after seeding in the CO2-containing atmosphere at 35˚C. The specimen tubes containing
the vaginal intrapartum E-Swab sample medium were subsequently frozen at minus 80˚C for
later PCR analysis. The Granada agar plates were read after one and two days of incubation.
All GBS-like colonies (identified by their orange color on Granada agar plates) were rou-
tinely confirmed as Streptococcus agalactiae using the Microflex LT ™ MALDI-TOF system
(Bruker Daltonik, Germany). A semi-quantitative culture assessment of GBS growth was con-
ducted in most cases. The culture was classified as having only growth of few GBS colonies (+),
some (++) or many (+++) by intrapartum vaginal culture.
Polymerase chain reaction (PCR)
PCR analysis is a real-time PCR test performed on the BDMaxTM system (Becton, Dickinson
and Company, USA) without enrichment of the specimen in a culture broth prior to analysis.
The BDMax™ System automatically extracts the target nucleic acid and amplifies a section of
the cfb gene sequence of the GBS genome if present. The BDMax™ Assay includes an Internal
Process Control to monitor for the presence of potential inhibitory substances as well as sys-
tem or reagent failures that may be encountered during the entire process. The results are
reported by the BDMax™ software as a qualitative answer, either positive or negative for GBS.
In a small number of cases, the specimens were initially undetermined because of inhibition,
reagent failure or system errors, which led to additional testing by taking a new aliquot of the
sample and repeating the DNA extraction and PCR assay. The PCR analyses were performed
retrospectively on frozen samples as batch processing.
The results of the GBS culture and PCR tests were read by independent laboratory techni-
cians and recorded separately.
Formalities
The study was approved by the Regional Scientific Ethical Committees for Southern Denmark
(S-20130089) and the Danish Data Protection Agency (2008-58-0035). The date of issue: 6
November 2013. All participants provided written informed consent.
Statistics
STATA Statistics/Data Analysis software (version 14; StataCorp LP) was used for the statistical
analysis. Sensitivity, specificity, positive predictive values (PPV), negative predictive values
Intrapartum PCR assay versus antepartum culture
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(NPV), and Likelihood ratio (LH) including 95% confidence intervals (CI) were calculated for
both antepartum GBS screening and the intrapartum PCR assay using culture of a vaginal
swab sample as the gold standard.
Results
All 979 enrolled women had an antepartum swab obtained as part of the culture-strategy and
902 (92%) had an intrapartum swab as part of the culture-based reference standard and the
PCR-strategy. The intrapartum vaginal GBS colonization rate detected by culture was 11.5%
(reference standard). By comparison, the culture-based strategy found 9.4% (85/902) GBS-pos-
itive women by combining results from antepartum vaginal and rectal swab cultures (7.4% by
vaginal swab samples and 8.9% by rectal samples) (Table 1), and the PCR-strategy (intrapar-
tum vaginal swab sample) found 12.2% GBS-positive women (Table 2).
Based on the reference standard, the performance characteristics of the culture-strategy and
the PCR-strategy are given in Tables 2 and 3. Notably, a marked difference between the posi-
tive likelihood ratios (LH+) of 9.2 for the culture-strategy and 27.5 for the PCR-strategy was
seen. The positive predictive value was 55% for combining antepartum vaginal and rectal swab
cultures and 78% for PCR-strategy.
The false negative rate by the PCR-strategy was 17% (18/104). Fourteen of these 18 false
negative samples were assessed by the semi-quantitative culture assessment, and among these
12 (86%) were classified with only few GBS colonies (Table 4). On the other hand, the false
positive rate was 3% (24/798).
Discussion
We evaluated two screening strategies for identification of vaginal GBS colonization in a Dan-
ish cohort of laboring women, using an intrapartum culture as the reference standard. The
antepartum culture-strategy achieved a LR+ of 9.2, whereas the intrapartum PCR-strategy
achieved a LR+ of 27.5.
The strength of our study is the size of the cohort consisting of 902 participants from a well-
defined population, which did not receive antibiotics between antepartum culture and the
time of labor. It might be considered as a limitation that the PCR analyses were performed ret-
rospectively as a batch processing of frozen samples thus only simulated as a rapid on-site test.
However, to create a realistic screening scenario for a rapid PCR-strategy we used a GBS PCR
assay without a delaying broth enrichment step prior to the PCR analysis. The Granada
medium for isolation and identification of GBS is a selective and differential culture medium
designed to selectively isolate Streptococcus agalactiae (Group B streptococcus, GBS) which dif-
fers from the standard recommended by CDC (Lim or TransVag).
The choice of a PCR assay for vaginal GBS detection performed without a prior Lim broth
enrichment was intended and thereby also to accept a small, however, statistically significant
lower sensitivity (92.7% versus 99.1%) compared to the use of the same PCR test with a Lim
broth inoculation of the specimen according to the study of Silbert et al. [24]. Using a prior 18
hours Lim broth enrichment step as part of the PCR assay would prohibit the use of the GBS
PCR as a rapid test at the time of delivery.
It may constitute a shortcoming of the study that omitting a prior enrichment step of the
specimen is likely to reduce the number of positive cases detected by not only the PCR assay
but also the intrapartum culture of the vaginal specimen. However, this approach allowed us
to conduct the semi-quantitation of the GBS in the vaginal sample. These results indicate that
the potential lower sensitivity of a PCR assay without a prior enrichment step with a false
Intrapartum PCR assay versus antepartum culture
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negative rate of 17% (18/104) is primarily caused by a failure to detect vaginal colonization
with low numbers of GBS, which may be of less risk for the newborn during birth.
The false positive rate was only 3%, and in fact, we find it likely that these women may also
be colonized with GBS, e.g., by non-hemolytic GBS isolates which may not be detectable on
Granada agar plates. However, it is a limitation of the PCR-strategy that 3.4% of all specimens
tested were initially undetermined for technical reasons based on the amplification status of
the target and the Internal Process Control (data not shown). In such cases, a repeat testing
must be conducted, which will delay the definitive result and may be in some cases not in time
to decide the use of preventive antibiotic prophylaxis.
In contrast, antepartum screening by a GBS culture or PCR test with or without a prior Lim
broth enrichment at week 35–37 during pregnancy is known to miss a substantial number of
women with later intrapartum carriage of GBS [12, 13, 21, 27]. Furthermore, it should be
noted that the difference in the detecting rates between the direct plating of the rectovaginal
swab on the Granada medium and plating after prior Lim broth enrichment is only 4% [28].
Our study is the first of its kind performed in a country such as Denmark where the risk
based approach is still recommended. This study is in line with prior studies reporting on the
usefulness of a PCR-strategy in detecting intrapartum GBS [12, 14, 22, 29–31]. The GBS car-
riage rate was only 12% compared to 10–29% in other studies [27, 32–36] comprising different
population and using other GBS detection methods based primarily on broth enrichment [2,
35, 37]. The difference between antepartum vaginal and rectal culture carriage (11% vs. 16%,
respectively) have also been shown in previous studies, supporting the hypothesis that the gas-
trointestinal tract is the primary reservoir of GBS, and that vaginal colonization represents
spread of GBS from rectum [34, 35].
Unlike other chromogenic media, the Granada medium cannot detect non-hemolytic GBS,
thereby potentially decreasing the sensitivity of this culture medium for GBS screening [20].
However, the frequency of non-hemolytic GBS isolates is around 5% among GBS carriers, and
Table 1. Concordance between detection of GBS colonization analyzed by antepartum culture (rectum and vaginal) and intrapartum culture
(vagina) as the reference standard.
Intrapartum vaginal culture (reference)
Positive Negative Total = 902
Antepartum culture N (%)
Vagina or rectum Positive 85 71 156 (17.3)
Negative 19 727 746
Vagina Positive 67 33 100 (11.1)
Negative 37 765 802
Rectum Positive 80 66 146 (16.2)
Negative 24 732 756
https://doi.org/10.1371/journal.pone.0180262.t001
Table 2. Detection of GBS colonization by intrapartum polymerase chain reaction test (PCR) compared to intrapartum vaginal culture as the refer-
ence standard.
Intrapartum vaginal culture (reference)
Positive Negative Total
Intrapartum vaginal PCR N (%)
104 (11.5) 798 (88.5) 902 (100)
Positive 86 (82.7) 24 110 (12.2)
Negative 18 774 (98.1) 792 (87.8)
https://doi.org/10.1371/journal.pone.0180262.t002
Intrapartum PCR assay versus antepartum culture
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a rate of only 1% is observed among invasive GBS strains, which suggests that EOGBS caused
by non-hemolytic GBS strains is negligible [38].
The PCR strategy does not allow for performing antimicrobial susceptibility testing, which
may be of relevance for penicillin-allergic patients. However, susceptibility testing is not neces-
sary in general because GBS isolates with confirmed resistance to penicillin, ampicillin, or cefa-
zolin have not yet been described [39]. Fortunately, efficient alternative choices exist for those
with known penicillin-allergy, e.g., cefuroxime, cefaclor, and ceftriaxone. In patients with a
history of severe anaphylactic reactions following cephalosporin treatment, vancomycin is an
alternative antibiotic [40].
We conclude that in a Danish population of pregnant women with a low risk for their
babies to acquire EOGBS, intrapartum PCR could be an efficient recommendation to screen
for vaginal carriage of GBS during labor. It remains, to be evaluated, however from a medical
technology perspective whether the test should be offered to all laboring women or only to
those with a predefined risk. Such a medical technology evaluation must take into account 1)
the fact that we have studied only proxy variables (GBS vaginal colonization) for EOGBS, 2)
the overall costs, 3) the risks of maternal anaphylactic reactions and sensitization, 4) the
Table 3. Performance of antepartum vaginal/rectal culture and intrapartum vaginal PCR test using
intrapartum vaginal culture for GBS as the reference standard.
Antepartum culture Intrapartum PCR
For GBS For GBS
Vagina Rectum Vagina or rectum Vagina
%, n/N 95% CI %, n/N 95% CI %, n/N 95% CI %, n/N 95% CI
Sensitivity 64
67/104
54–74 77
80/104
68–85 82
85/104
73–89 83
86/104
74–89
Specificity 96
765/798
94–97 92
732/798
90–94 91
727/798
89–93 97
774/798
96–98
PPV 67
67/100
55–74 55
80/146
46–63 55
85/156
46–63 78
86/110
69–86
NPV 95
765/802
94–97 97
732/756
95–98 98
727/746
96–99 98
774/792
96–99
LH+ 16
65/1-96
11–22 9
77/1-92
7–12 9
82/1-91
7–12 27
83/1-97
18–41
CI = confidence interval; PPV = positive predictive value; NPV = negative predictive value; LH = Likelihood
ratio
https://doi.org/10.1371/journal.pone.0180262.t003
Table 4. Association between PCR and culture with semi-quantitative assessment of intrapartum vaginal growth of GBS in sample.
Intrapartum vaginal culture (reference) (N = 902)
Positive Negative
Intrapartum vaginal PCR Semi-quantification
+ ++ +++ Not assessed
Positive 10 17 36 23 24
Negative 12 1 1 4 774
+++
= many
++
= some
+
= growth of few GBS colonies
https://doi.org/10.1371/journal.pone.0180262.t004
Intrapartum PCR assay versus antepartum culture
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possible adverse effects of antibiotics on the microbiome of the mother and the newborn [41],
and 5) the risk of promoting drug resistance among the bacteria.
It should be noted that there are some practical demands of an intrapartum PCR test. It
should first of all be simple for midwives or nurses to perform, and they should also be able to
expect a test result made available within a relatively short time, which is necessary for the
decision whether or not to administer antibiotics in a busy labor and delivery ward. In some
urgent clinical cases, a PCR result may be required within less than 120 minutes, which is pos-
sible with the present PCR assay when a few patient samples are handled at a time.
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